Hakutulokset - Peter Meldgaard

ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approach Tekijä Lærke Rosenlund Nielsen, Simone Stensgaard, Peter Meldgaard, Boe Sandahl Sorensen

Hae kokoteksti

Cell‐free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients Tekijä Christoffer Trier Maansson, Peter Meldgaard, Magnus Stougaard, Anders Lade Nielsen, Boe Sandahl Sorensen

Hae kokoteksti

Dasatinib and Doxorubicin Treatment of Sarcoma Initiating Cells: A Possible New Treatment Strategy Tekijä Ninna Aggerholm-Pedersen, Christina Demuth, Akmal Safwat, Peter Meldgaard, Moustapha Kassem, Boe Sandahl Sorensen

Hae kokoteksti

EGFR transcription in non‐small‐cell lung cancer tumours can be revealed in ctDNA by cell‐free chromatin immunoprecipitation (cfChIP) Tekijä Christoffer Trier Månsson, Johan Vad‐Nielsen, Peter Meldgaard, Anders Lade Nielsen, Boe Sandahl Sorensen

Hae kokoteksti

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer Tekijä Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen

Hae kokoteksti

DNAfusion: an R/Bioconductor package for increased sensitivity of detecting gene fusions in liquid biopsies Tekijä Christoffer Trier Maansson, Emma Roger Andersen, Maiken Parm Ulhoi, Peter Meldgaard, Boe Sandahl Sorensen

Hae kokoteksti

Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancer Tekijä Torben Steiniche, Jeanette Baehr Georgsen, Peter Meldgaard, Anne C. Deitz, Mark Ayers, M. Catherine Pietanza, Ke Zu

Hae kokoteksti

Intra‐individual variation of circulating tumour DNA in lung cancer patients Tekijä Johanne A. Hojbjerg, Anne T. Madsen, Hjordis H. Schmidt, Steffen F. Sorensen, Magnus Stougaard, Peter Meldgaard, Boe S. Sorensen

Hae kokoteksti

Mapping the mutational terrain of lung adenocarcinoma: A Danish cohort study of 880 patients Tekijä Jeanette Bæhr Georgsen, Maria Vad Jakobsen, Peter Meldgaard, Johanne Lade-Keller, Peter Jepsen, Patricia Switten Nielsen, Lena Dyrborg, Torben Steiniche

Hae kokoteksti

In vitro size-selection of short circulating tumor DNA fragments from late-stage lung cancer patients enhance the detection of mutations and aneuploidies Tekijä Christoffer Trier Maansson, Louise Skov Thomsen, Laura Stokkebro, Julie Gabe Dissing, Maiken Parm Ulhoi, Anders Lade Nielsen, Peter Meldgaard, Boe Sandahl Sorensen

Hae kokoteksti

Clinical and molecular characteristics of 42 Danish patients with metastatic ALK fusion-positive lung cancer treated with first-line alectinib: A nationwide study Tekijä Maiken Parm Ulhøi, Emma Roger Andersen, Christoffer Trier Maansson, Lars Munch Larsen, Miroslaw Stelmach, Jon Lykkegaard Andersen, Karin Holmskov Hansen, Tine McCulloch, Bo Sorensen, Peter Meldgaard

Hae kokoteksti

Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer usi... Tekijä Theresa May, Michelle S. Clement, Harkanwal Halait, Alexander Kohlmann, Milena Kohlmann, Jason Lai, Nitta Lee, Xiaocheng Li-Sucholeiki, Peter Meldgaard, Snehal Joshi, Sidney Scudder, Neelima Shrestha, Boe Sorensen, Marilyn Kiral, Patrick O’Donnell

Hae kokoteksti

Impact of multidisciplinary team discrepancies on comparative lung cancer outcome analyses and treatment equality Tekijä Torben Riis Rasmussen, Anja Gouliaev, Erik Jakobsen, Karin Hjorthaug, Lene Unmack Larsen, Peter Meldgaard, Jesper Thygesen, Rana Bibi, Lars B. Møller, Arman Arshad, Birgitte Folkersen, Anette Højsgaard, Zaigham Saghir, Klaus R. Larsen, Jesper Ravn

Hae kokoteksti